ArticleAnnals of translational medicine2022
Effects of β-blockers therapy on the 28-day and 3-year survival rates of end-stage renal disease patients with cardiovascular disease: a retrospective cohort study.
Yong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.